A remarkable number of life-threatening diseases manifest more severely in males than in females. One current example is COVID-19 caused by SARS CoV-2. Another example is...
“Winter is coming” – could it fuel another surge in COVID-19 cases in the United States? Morgan Stanley’s biotech analyst Matthew Harrison thinks so. But on...
Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of The post The ‘patient of the future’ is...
Around half of recent excess deaths in England have been directly from COVID.
FoundersHK was created to strengthen Hong Kong’s startup community, which has weathered more than two years of political turmoil, along with the COVID-19 pandemic. Today the...
Moderna (MRNA) makes a strong case to be known as one of the top innovators on the planet. The company's breakthrough vaccine, now referred to as...
These health care stocks could be the booster for your portfolio right now. The post 4 Top Health Care Stocks To Watch After Merck’s COVID-19 Pill...
To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections,...
The human body has built-in protections to keep pathogens out. Credit: Photo by Kathy F. Atkinson The human body has built-in protections to keep pathogens out....
Janssen Pharmaceutical's experimental vaccine for a respiratory syncytial virus (RSV) demonstrated an 80 percent efficacy level in adults over the age of 65 years.
Just days after Thermo Fisher Scientific prepped to expand a St. Louis plant, the company announced it’s taking over a new, 1.5 million-square-foot site in Switzerland...
Carnival (CCL), and the broader cruise line space, have struggled to bounce back from the COVID-19 crash. While shares of many companies have surged above and...
Fauci Isn't Sure You Can Gather For Xmas, But Is Sure You Must Give Up Your Individual Rights Authored by Thomas Lifson via AmericanThinker.com, The highest...
Profit-taking forces the US dollar lower With US stock markets finishing Friday on a positive note, boosted by Merck’s oral Covid-19 treatment that lifted hopes of...
Evergrande weighing on Japan and Hong Kong markets US markets started the quarter strongly on Friday, boosted by positive results from a trial of Merck’s oral...
It seems we’ve all had a rough year and a half. For some of us, the experience of the pandemic has exacerbated vulnerabilities we already have....
Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its The post Merck preps filings for oral COVID...
M3’s Tim Russell and Maxim Polyakov, together with Digital Futureway’s Heather Hancock, discuss new research on how doctor The post The post-pandemic evolution of pharma-doctor digital...
Merck & Company (MRK) gained over 8% to close at $81.40 on October 1. Merck is a biopharmaceutical firm whose main product is the PD-L1 inhibitor...
Public-health messaging and strained health-care resources during COVID-19 have meant fewer in-person exams. For some children with brain cancer, this can have devastating consequences.
India's Ivermectin Blackout: The Secret Revealed Authored by Justus R, Hope via TheDesertReview.com, On May 7, 2021, during the peak of India's Delta Surge, The World...
Welcome to TDR’s review of the Top 5 Psychedelic developments for the week of September 27. Aside from presenting a synopsis of events, we provide market...
Another Tempestuous Balkan Pot Is Boiling Authored by Stephen Karganovic via The Strategic Culture Foundation, As relations between major geopolitical players steadily deteriorate the Balkans are...
On Friday, Merck & Co Inc. (NYSE:MRK) shares spiked more than 9% after announcing positive developments in its covid-19 pill. The company with Ridgeback Biotherapeutics are...
Do these biotech stocks have huge upside potential? The post 4 Top Biotech Stocks To Watch In October 2021 appeared first on Stock Market News, Quotes,...
"It Really Is THAT Good" - Wall Street Reacts To Merck's "Big Deal" Drug As we reported earlier this morning, Merck has released what experts say...
Stocks Pressured After Fitch Warns Debt Ceiling "Brinksmanship" Threatens US AAA Rating Ready for a rerun of August 2011? As a reminder, just over 10 years...
Merck is at 52-week highs after the health-care giant reported progress with its Covid treatment. Here's the chart and outlook.
Merck said data from the Phase III MOVe-OUT trial showed that 28 of 385 patients (7.3%) who received molnupiravir were either hospitalized or died through Day...
More houses of worship are offering mental health programs, especially African American congregations.